Ferring Therapeutics Private Limited, a active private limited company, was established on 28 November 2011 in Thane, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U74120MH2011PTC224424. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹300.00 Cr and a paid-up capital of ₹272.85 Cr.
It upholds a compliant status. Employing 84 professional, Its leadership includes Jens Eric Regelin (Director), Anindya Ghosh (Managing Director), Robert Flury (Director). Past directors included Jens Eric Regelin, Carsten Hjorth Jensen, Suresh Pattathil. It holds ₹2.00 Cr open charges and no settled loans. Its latest AGM occurred on 19 July 2024, with the balance sheet filed on 31 December 2023. It is based at Plot No. K-28/1, Additional Midc, Anand Nagar, Ambernath (E), Thane, Maharashtra, 421506.
U74120MH2011PTC224424
224424
28 November 2011
₹300.00 Cr
₹272.85 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Ferring Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jens Eric Regelin | Director | 13 Oct 2020 | Current |
| Anindya Ghosh | Managing Director | 01 Dec 2016 | Current |
| Robert Flury | Director | 13 Apr 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 21 Jun 2021 | Past |
| Pramod Abcsdd | Director | 01 Jan 2021 | Past |
| Pramod Abcsdd | Director | 01 Apr 2020 | Past |
| Pramod Abcsdd | Additional Director | 01 Jan 2017 | Past |
| Pramod Abcsdd | Director | 27 Jun 2013 | Past |
| Pramod Abcsdd | Managing Director | 01 Jan 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ferring Therapeutics Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 19.91% increase. The company also saw a substantial fall in profitability, with a 26.5% decrease in profit. The company's net worth moved up by a moderate rise of 4.23%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Ferring Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹20,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Dec 2022 | The Hongkong And Shanghai Banking Corporation Limited | ₹2.00 Cr | Open |
Explore comprehensive loan charge details -
Ferring Therapeutics has a workforce of 84 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Ferring Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ferring Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Piyali Pratibharanjan Das was appointed as a Company Secretary was appointed as a Company Secretary on 09 Sep 2024 & has been associated with this company since 1 year 2 months . was documented.
Ferring Therapeutics Private Limited last Annual general meeting of members was held on 19 Jul 2024 as per latest MCA records. was recorded as a recent event.
Progress on Ferring Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Dec 2023 with Roc Mumbai. was documented.
The activity A charge with The Hongkong And Shanghai Banking Corporation Limited amounted to Rs. 2.00 Cr with Charge ID 100659035 was registered on 20 Dec 2022. was completed.
The activity Robert Flury was appointed as a Director was appointed as a Director on 13 Apr 2022 & has been associated with this company since 3 years 7 months . was completed.
Jens Eric Regelin was appointed as a Director was appointed as a Director on 13 Oct 2020 & has been associated with this company since 5 years 1 month . was recorded as a recent event.
The CIN of Ferring Therapeutics Private Limited is U74120MH2011PTC224424.
Ferring Therapeutics Private Limited is headquartered at Plot No. K-28/1, Additional Midc, Anand Nagar, Ambernath (E), Thane, Maharashtra, 421506.
Ferring Therapeutics Private Limited was incorporated on 28 November 2011.
The current directors of Ferring Therapeutics Private Limited are
The primary industry of Ferring Therapeutics Private Limited is Manufacturing.
Ferring Therapeutics Private Limited is unlisted.
The authorized capital of Ferring Therapeutics Private Limited is ₹300.00 Cr, and the paid-up capital is ₹272.85 Cr.
The compliance status of Ferring Therapeutics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX